期刊文献+

家庭监测型心脏转复除颤器术后管理的安全性及有效性 被引量:2

The safety and effectivity of home monitoring function in the postoperative management of implantable cardioverter defibrillator
原文传递
导出
摘要 目的探讨家庭监测(HM)功能在埋藏式心脏转复除颤器(ICD)患者随访中的作用及意义。方法分析15例行HM型ICD植入患者的临床资料,与术后传统诊室随访方式相对比,评价远程HM获得的起搏系统参数的可靠性,并分析不同类型的报警信息,通过电话指导或必要时诊室随访的方式进行处理。结果 15例出院前HM方法与同一时间诊室随访方法所测定的右室除颤电极感知数值(r=0.97,P<0.01)、起搏阻抗数值(r=0.92,P<0.01)及除颤阻抗数值(r=0.98,P<0.01)有强相关性。随访(283.9±271.3)天,网上传输中观察到200次报警事件,其中临床相关事件共报警121次,较常规诊室随访提前发现临床事件(77.5±44.5)天,及时发现了电风暴,电极脱位和ICD误诊断,误放电等不良事件。12例(80%)通过电话远程调整治疗方案,3例(20%)提前诊室随访。结论 ICD患者通过HM功能进行术后随访是安全可靠的,通过HM可提前发现起搏系统异常及临床事件,利于及时调整治疗方案,优化术后的管理。 Objective To investigate the effect and the significance of home monitoring(HM) during the follow-up of high risk patients with implantable cardioverter defibrillator (ICD). Methods Fifteen high risk patients who implanted with HM function of ICD were enrolled in this study. Compared with the conventional office visits, the parameters of defib- rillator device and the different types of remote alert messages delivered by HM were analyzed and then dealt with by remote telephone suggestion or by office visits back to hospital if necessary. Results In 15 patients, the lead parameters a- chieved by office visits were compared by remote HM before discharge , there were significant correlations in the sensitivity of defibrillator leads, the pacing impendence and defibrillation impendence(P〈0. 01 ). 200 alert messages were detected by the HM during a mean follow-up of (283.9±271.3) days, including 121 clinical relative transmissions, and HM could find the clinical events earlier than conventional office visits for mean ( 77.5±44.5 ) days, such as electrical storm, lead dislocation and false diagnosis and inappropriate shock. Among all the patients, the alert messages of 12 patients ( 80% ) were dealt with by remote telephone suggestion and the other 3 patients were requested to the office visits ahead of schedule. Conclusions HM is a safe and reliable method during the follow-up of ICD patients. The function of HM could enhance discovery, facilitate the decisions timely and optimize the management of ICD.
出处 《中国心脏起搏与心电生理杂志》 2014年第4期308-311,共4页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心血管病学 家庭监测 埋藏式心脏转复除颤器 随访 Cardiology Home monitoring Implantable cardioverter defibrillator Follow-up
  • 相关文献

参考文献8

  • 1张澍,陈柯萍,黄德嘉,宿燕岗,华伟,吴立群,周胜华,沈法荣,王景峰,陈泗林,杨杰孚,汤宝鹏,郭涛,程晓曙,黄从新,王方正.心血管植入型电子器械术后随访的专家共识[J].中华心律失常学杂志,2012,16(5):325-329. 被引量:25
  • 2Jung W, Rillig A , Birkemeyer R, et al. Advances in remote moni- toring of implantable pacemakers , cardioverter defibrillators and cardiac resynchronization therapy systems [ J ]. J Inten, Card Elec- trophysio1,2008,23 ( 1 ) :73. 被引量:1
  • 3Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities: a report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines (WritingCommittee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia De- vices) : developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons [ J ]. Circulation, 2008,117(21 ) :350. 被引量:1
  • 4Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trim ) [J]. Eur Heart J,2012,33(9) :1 105. 被引量:1
  • 5van Rees JB, Borleffs CJ, de Bie MK, et al. Inappropriate implant- able eardioverter-defibrillator shocks : incidence, predictors, and impact on mortality [J]. J Am Coil Carcliol, 2011,57(5) :556. 被引量:1
  • 6Varma N, Michalski J, Epstein AE, et al. Automatic remote moni- toring of implantable cardioverter-defibrillator lead and generator per- formance:the lumos-t safely reduces routine office device follow-up (TRUST) trial [ J ]. C irc Arrhythm Electrophysiol, 2010,3 ( 5 ) :428. 被引量:1
  • 7Spencker S, Coban N, Koch L, et al. Potential role of home moni- toring to reduce inappropriate shocks in implantable cardioverter-de- fibrillator patients due to lead failure [ J ]. Europace,2009,11 (4) : 483. 被引量:1
  • 8Gu6don-Moreau L, Chevalier P, Marqui6 C, et al. Contributions of remote monitoring to the follow-up of implantable cardioverter-defib- rillator leads under advisory [J]. Eur Heart J,2010,31 (18) :2 246. 被引量:1

二级参考文献20

  • 1王方正,张澍,华伟,胡大一,陈新.全国心脏起搏器临床应用调查(2002至2005年)[J].中华心律失常学杂志,2006,10(6):475-478. 被引量:21
  • 2Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities:a report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines. ( Writ- ing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol,2008,51 : e1-62. 被引量:1
  • 3Dickstein K,Vardas PE,Aurlcchio A, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribu- tion of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail,2010,12 : 1143-1153. 被引量:1
  • 4McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute mad chronic heart failure 2012. Eur J Heart Fail,2012,14 : 803- 869. 被引量:1
  • 5Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert con- sensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs) : Description of techniques, indications, person- nel, frequency and ethical considerations. Europace, 2008, 10: 707-725. 被引量:1
  • 6Haycs DL, Naccarelli GV, Fuman S, et al. North American Society to Pacing and Electrophysiology. NASPE training requirements for cardiae implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Eleetrophysiol,2003,26 : 1556-1562. 被引量:1
  • 7Naccarelli GV,Conti JB, DiMarco JP,et al. 2008 COCATS 3 Tack Force 6: training in specialized electrophysiology,cardiac pacing, and arrhythmia management. Heart Rhythm ,2008,5:332-337. 被引量:1
  • 8Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol, 2005,28 : 235 -240. 被引量:1
  • 9Joseph GK, Wilkoff BL, Dresing T, et al. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol,2004,11 : 161-166. 被引量:1
  • 10Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of au- tomatic remote monitoring for implantable cardioverter-defibrilla- tot follow-up: The Lumos-T Safely Reduces Routine Office De- vice Follow-up (TRUST) trial. Circulation,2010,122:325-332. 被引量:1

共引文献24

同被引文献45

  • 1Varma N, Michalski J, Epstein AE,et al. Remote monitoring of im- plantable cardioverter-defibrillator lead and generator performance the Lumos-T safely reduces routine office device follow-up (TRUST) trial[ J]. Circ Arrhythm Electrophysiol,2010, 3 (5) :428. 被引量:1
  • 2Crossley GH, Boyle A, Vitense H, et al. CONNECT Investigators. The CONNECT ( Clinical evaluation of remote notification to reduce time to clinical decision) triM:the value of wireless remote monito-ring with automatic clinician alerts[ J]. J Am Coil CardioI,2011,57 (10) :1 181. 被引量:1
  • 3Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow- up: the ALTITUDE survival study [ J ]. Circulation,2010,122 (23) : 2 359. 被引量:1
  • 4Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[ J]. Circulation, 2012,126(14) :1 784. 被引量:1
  • 5Omera O, Bulava A. The benefits of remote monitoring in long-term care for patients with implantable cardioverter-defibrillators [ J ]. Neuro Endocrinol Lett ,2014,35 (Suppl 1 ) :40. 被引量:1
  • 6Varma N, Pavri BB, Stambler B, et al. Same-day discovery of im- plantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems[ J] . Eu- ropace,2013,15 (5) :697. 被引量:1
  • 7Gu6don-Moreau L, Chevalier P, Marqui6 C, et al. Contributions of remote monitoring to the follow-up of implantable cardioverter - de- fibrillator leads under advisory[ J]. Eur Heart J, 2010, 31 (10) :2 246. 被引量:1
  • 8Gurdon-Moreau L, Lacroix D, Sadou! N, et al. A randomized study of remote foUow-up of implantab|e cardioverter defibrillators: safety and efficacy report of the ECOST trial[J]. Eur Heart J, 2013, 34 (8) :605. 被引量:1
  • 9Gudon-Moreau L, Kouakam C, Klug D ,et al. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a Sub- study of the ECOST Trial[ J]. J Cardiovasc Electrophysiol,2014,25 (7) :763. 被引量:1
  • 10Rieci RP, Morichelli L, Santini M,et al. Remote control of implan- ted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation [ J ]. Enropaee, 2009, 11(1) :54. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部